Consensus Guidelines for the Use of Cyclin-Dependent Kinase (CDK) 4/6 Inhibitors in the Management of Hormone Receptor Positive (HR+ve), Her2-ve Early Breast Cancer (EBC) [0.03%]
周期依赖激酶（CDK）4/6抑制剂在激素受体阳性（HR+ve），Her2-阴性早期乳腺癌（EBC）管理中使用共识指南
Purvish M Parikh,Amish Vora,Rajan Yadav et al.
Purvish M Parikh et al.
It is still not possible for all patients with early breast cancer to be cured. Even when they respond well to initial therapy, there exists a substantial risk for recurrence, sometimes after several years. With the availability of cyclin-d...
Clinicopathological Evaluation of Patients with Hormone Receptor-Positive HER2-Negative Metastatic Breast Cancer Progressing on Endocrine Treatment: A Real-World Retrospective Study from a Regional Cancer Center [0.03%]
荷尔蒙受体阳性HER2阴性转移性乳腺癌在内分泌治疗进展后的临床病理评估：一个来自区域癌症中心的真实世界回顾性研究
S Shanthala,Usha Amirtham,K N Lokesh et al.
S Shanthala et al.
Metastatic breast cancer (MBC) is an incurable disease with the primary aim of treatment being the improvement of the patient's quality of life and the delay of disease progression. A substantial proportion of patients with hormone receptor...
Delay from Onset of Symptoms to Reporting at a Cancer Care Facility and the Impact of Alternate Medicine Usage as a Contributing Factor [0.03%]
从出现症状到在癌症护理机构报告的延迟以及替代医学使用作为影响因素的作用
V Seenu,Pratibha Kole,Suman Dhabal
V Seenu
Cancer patients often present after a period of certain delay from onset of symptoms. By tradition, alternate medicine has been the commonly sought after remedy for them. The objective of this study was to evaluate the delay in presentation...
Estimation of Hand Function Impairment in Breast Cancer Survivors with Lymphedema [0.03%]
淋巴水肿乳腺癌幸存者手功能障碍的评估
Sandeep B Shinde,Pooja P Jain,Diksha S Jagwani et al.
Sandeep B Shinde et al.
Breast cancer (BC) is one of the most frequent cancers in women, and breast cancer-related lymphedema (BCRL) is a common side effect of BC treatment. When the lymphatic drainage system is damaged, lymphedema develops, which further exacerba...
A Multicenter Study on the Challenges and Real-World Utilization of Immune Checkpoint Inhibitors in Resource-Constrained Settings: Insights and Implications from India [0.03%]
资源有限环境下免疫检查点抑制剂的挑战及实际应用的多中心研究：来自印度的见解与意义
Ashwin Oommen Philips,Sunu Cyriac,P Unnikrishnan et al.
Ashwin Oommen Philips et al.
Using immune checkpoint inhibitors (ICIs) has revolutionized cancer treatment, but access and affordability remain significant challenges, particularly in resource-constrained settings. This multicenter study evaluated the utilization, outc...
Efficacy and Safety Profile of Different Schedules of Adjuvant Trastuzumab Therapy among Patients with HER2-Positive Breast Cancer: Real-World Experience from a Tertiary Cancer Center in South India [0.03%]
不同疗程的辅助曲妥珠单抗治疗在HER2阳性乳腺癌患者中的有效性和安全性：来自南印度一家三级癌症中心的真实世界经验
Nandini Devi Rajan,Abhilash Menon,Praveen Kumar Shenoy et al.
Nandini Devi Rajan et al.
One year of adjuvant trastuzumab is the standard of care for HER2-positive breast cancer. In low-middle income countries, delivery of 1-year trastuzumab is challenging due to significant financial burden. Evidence for shorter durations of a...
A Prospective Study on the Use of Deep Inspiration Breath-Hold Technique in External Beam Radiotherapy for Breast Cancer [0.03%]
深吸气后屏气技术在外照射乳腺癌放疗中应用的前瞻性研究
Nijo Jose,Jayashree N P,Shirley Lewis et al.
Nijo Jose et al.
Background: Breast cancer is the most common cancer and the leading cause of death in women. The deep inspiration breath-hold (DIBH) technique helps reduce the dose received by the heart and lungs in breast cancers during...
Tumor Budding: A Novel Prognostic Marker in Breast Carcinoma with Correlation of Histopathological and Immunohistochemical Parameters [0.03%]
肿瘤种植：乳腺癌的一个新预后标志物，并对组织病理学和免疫组化参数进行关联分析
Poornima Manimaran,Ashini Shah,Amisha Gami et al.
Poornima Manimaran et al.
Introduction: Breast cancer is a highly heterogenous tumor with different subtypes showing varying prognosis. Tumor budding is an unfavorable histological feature of many epithelial cancers. The purpose of this study is t...
Technology and Innovation Has Made Impact Factor Redundant-Better Alternatives Are Here to Thrive [0.03%]
技术和创新使得影响因子变得多余了-更好的替代方案已经出现并蓬勃发展
Purvish M Parikh,Amish Vora
Purvish M Parikh
Role of Image-Guided Biopsy in Nonpalpable Breast Lesions: A Study in the Sub-Himalayan Region of North India [0.03%]
图像引导活检在喜马拉雅山地北印度地区非扪及乳腺病灶中的作用研究
Surya Pratap Singh,Charu Smita Thakur,Sushma Makhaik et al.
Surya Pratap Singh et al.
Background: Nonpalpable breast lesions pose a challenge in their early diagnosis. Image-guided biopsy is preferred in these cases so that a pathological diagnosis of breast carcinoma is reached timely for a better prognos...